• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一家中国三级综合医院8年期间不同免疫状态诺卡菌病患者的特征:一项遵循STROBE标准的观察性研究

Characteristics of nocardiosis patients with different immune status from a Chinese tertiary general hospital during 8-year period: A STROBE-compliment observational study.

作者信息

Huang Lei, Sun Liying, Yan Yan

机构信息

Department of Clinical Laboratory, Peking University First Hospital, Beijing, China.

出版信息

Medicine (Baltimore). 2019 Nov;98(45):e17913. doi: 10.1097/MD.0000000000017913.

DOI:10.1097/MD.0000000000017913
PMID:31702669
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6855654/
Abstract

Nocardia is an opportunistic pathogen from environment, which is generally thought to infect immunosuppressed patients (ISPs), but recent studies showed it could also cause infections in immunocompetent patients (ICPs).The aim of this study was to compare the clinical characteristics, patients' outcome, Nocardia species' identification, and antibiotic susceptibility profiles of nocardiosis between ICPs and ISPs.The detailed clinical data were collected from all the nonrepetitive nocardiosis patients during 2011 and 2018, from a tertiary general hospital in Beijing, China. Then each Nocardia isolate was identified to species level by DNA sequencing. The antibiotic susceptibility testing was performed by E test method, and interpreted following CLSI M24 document. The clinical and microbiological characteristics between ICPs and ISPs were compared statistically.A total of 23 nonrepetitive nocardiosis patients with detailed clinical data were enrolled in this study. Among them, 9 were ICPs and 14 were ISPs. All the skin and soft tissue infections occurred in ICPs (33.3% vs 0%, P < .05). Bronchiectasis occurred more frequently in ICPs (44.4% vs 21.4%), whereas chronic kidney diseases and coinfection with aspergillosis occurred more frequently in ISPs (35.7% vs 0%, 35.7% vs 0%, respectively), although they did not reach the statistical significance. There were no significant differences in other clinical characteristics, Nocardia species' identification, and antibiotic susceptibility between ISPs and ICPs (P > .05).Nocardiosis could occur in both ISPs and ICPs. Skin and soft tissue infection and bronchiectasis occurred more frequently in ICPs. Chronic kidney diseases and co-infection with aspergillosis occurred more frequently in ISPs. These characteristics should be noticed by physicians in diagnosis of nocardiosis.

摘要

诺卡菌是一种来自环境的机会致病菌,通常认为它会感染免疫抑制患者(ISP),但最近的研究表明它也可能导致免疫功能正常患者(ICP)感染。本研究的目的是比较ICP和ISP之间诺卡菌病的临床特征、患者预后、诺卡菌菌种鉴定及抗生素敏感性谱。详细的临床数据收集自2011年至2018年期间中国北京一家三级综合医院的所有非重复性诺卡菌病患者。然后通过DNA测序将每个诺卡菌分离株鉴定到种水平。采用E试验法进行抗生素敏感性试验,并按照CLSI M24文件进行解读。对ICP和ISP之间的临床和微生物学特征进行统计学比较。本研究共纳入23例具有详细临床数据的非重复性诺卡菌病患者。其中,9例为ICP,14例为ISP。所有皮肤和软组织感染均发生在ICP中(33.3%对0%,P<0.05)。支气管扩张在ICP中更常见(44.4%对21.4%),而慢性肾脏病和曲霉合并感染在ISP中更常见(分别为35.7%对0%,35.7%对0%),尽管未达到统计学意义。ISP和ICP在其他临床特征、诺卡菌菌种鉴定及抗生素敏感性方面无显著差异(P>0.05)。诺卡菌病可发生在ISP和ICP中。皮肤和软组织感染及支气管扩张在ICP中更常见。慢性肾脏病和曲霉合并感染在ISP中更常见。医生在诊断诺卡菌病时应注意这些特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/824a/6855654/7059c9ead3bb/medi-98-e17913-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/824a/6855654/7059c9ead3bb/medi-98-e17913-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/824a/6855654/7059c9ead3bb/medi-98-e17913-g002.jpg

相似文献

1
Characteristics of nocardiosis patients with different immune status from a Chinese tertiary general hospital during 8-year period: A STROBE-compliment observational study.一家中国三级综合医院8年期间不同免疫状态诺卡菌病患者的特征:一项遵循STROBE标准的观察性研究
Medicine (Baltimore). 2019 Nov;98(45):e17913. doi: 10.1097/MD.0000000000017913.
2
Clinical characteristics of pulmonary nocardiosis in immunocompetent patients.免疫功能正常患者肺诺卡菌病的临床特征
J Infect Chemother. 2016 Nov;22(11):738-743. doi: 10.1016/j.jiac.2016.08.004. Epub 2016 Sep 5.
3
Impact of immune status on the clinical characteristics, treatment outcomes and mortality of pulmonary nocardiosis: a retrospective analysis in a tertiary care hospital from a low- to middle-income country.免疫状态对肺奴卡菌病的临床特征、治疗结局和死亡率的影响:来自中低收入国家一家三级医院的回顾性分析。
Monaldi Arch Chest Dis. 2023 Jun 26;94(2). doi: 10.4081/monaldi.2023.2499.
4
Clinical features, identification, antimicrobial resistance patterns of Nocardia species in China: 2009-2017.中国诺卡氏菌属的临床特征、鉴定及抗菌药物耐药模式:2009-2017 年。
Diagn Microbiol Infect Dis. 2019 Jun;94(2):165-172. doi: 10.1016/j.diagmicrobio.2018.12.007. Epub 2018 Dec 29.
5
Clinical characteristics, microbiology, and outcomes for patients with lung and disseminated nocardiosis in a tertiary hospital.一家三级医院中肺诺卡菌病和播散性诺卡菌病患者的临床特征、微生物学及转归
J Formos Med Assoc. 2015 Aug;114(8):742-9. doi: 10.1016/j.jfma.2013.07.017. Epub 2013 Sep 3.
6
Nocardia infection over 5 years (2011-2015) in an Italian tertiary care hospital.意大利一家三级护理医院5年(2011 - 2015年)期间的诺卡菌感染情况。
New Microbiol. 2018 Apr;41(2):136-140.
7
Revisiting nocardiosis at a tertiary care institution: Any change in recent years?再次探讨三级医疗机构的奴卡菌病:近年来有任何变化吗?
Int J Infect Dis. 2021 Jan;102:446-454. doi: 10.1016/j.ijid.2020.10.087. Epub 2020 Nov 3.
8
Impact of immune status on the clinical characteristics and treatment outcomes of nocardiosis.免疫状态对诺卡菌病临床特征及治疗结果的影响。
Diagn Microbiol Infect Dis. 2016 Aug;85(4):482-7. doi: 10.1016/j.diagmicrobio.2016.05.004. Epub 2016 May 12.
9
Molecular identification of nocardia isolates from clinical samples and an overview of human nocardiosis in Brazil.从临床样本中分离出的诺卡菌的分子鉴定及巴西人类诺卡菌病概述。
PLoS Negl Trop Dis. 2013 Dec 5;7(12):e2573. doi: 10.1371/journal.pntd.0002573. eCollection 2013.
10
Different faces of Nocardia infection in renal transplant recipients.肾移植受者中诺卡菌感染的不同表现
Nephrology (Carlton). 2016 Mar;21(3):254-60. doi: 10.1111/nep.12585.

引用本文的文献

1
Clinical characteristics and drug resistance of Nocardia in Henan, China, 2017-2023.中国河南 2017-2023 年诺卡菌的临床特征及耐药性
Ann Clin Microbiol Antimicrob. 2024 Mar 6;23(1):23. doi: 10.1186/s12941-024-00677-4.
2
Pulmonary and central nervous system nocardiosis: Alcoholism as an immunocompromising factor.肺和中枢神经系统诺卡菌病:酗酒作为一种免疫受损因素。
Biomedica. 2023 Mar 30;43(1):37-43. doi: 10.7705/biomedica.6606.
3
Nocardiosis: A two-center analysis of clinical characteristics.诺卡菌病:一项双中心临床特征分析

本文引用的文献

1
Manifestations and outcomes of nocardia infections: Comparison of immunocompromised and nonimmunocompromised adult patients.诺卡菌感染的表现及结局:免疫功能低下与非免疫功能低下成年患者的比较
Medicine (Baltimore). 2018 Oct;97(40):e12436. doi: 10.1097/MD.0000000000012436.
2
Identification and antimicrobial susceptibility of clinical Nocardia species in a tertiary hospital in China.中国一家三甲医院临床诺卡菌属的鉴定及药敏分析。
J Glob Antimicrob Resist. 2017 Dec;11:183-187. doi: 10.1016/j.jgar.2017.08.011. Epub 2017 Sep 1.
3
Outcome and Treatment of Nocardiosis After Solid Organ Transplantation: New Insights From a European Study.
Front Med (Lausanne). 2022 Nov 16;9:996442. doi: 10.3389/fmed.2022.996442. eCollection 2022.
4
Infection in Nephrotic Syndrome Patients: Three Case Studies and A Systematic Literature Review.肾病综合征患者的感染:三个病例研究和系统文献回顾。
Front Cell Infect Microbiol. 2022 Jan 24;11:789754. doi: 10.3389/fcimb.2021.789754. eCollection 2021.
5
Molecular identification and antibiotic resistance pattern of actinomycetes isolates among immunocompromised patients in Iran, emerging of new infections.伊朗免疫功能低下患者放线菌属分离株的分子鉴定及抗生素耐药模式:新感染的出现。
Sci Rep. 2021 May 24;11(1):10745. doi: 10.1038/s41598-021-90269-5.
6
Cushing's Syndrome With Nocardiosis: A Case Report and a Systematic Review of the Literature.库欣综合征合并奴卡菌病:病例报告及文献系统回顾。
Front Endocrinol (Lausanne). 2021 Mar 29;12:640998. doi: 10.3389/fendo.2021.640998. eCollection 2021.
7
[Abscesos cerebrales por Nocardia spp. en una paciente inmunocompetente].[免疫功能正常患者的诺卡菌属脑脓肿]
Biomedica. 2020 Jun 15;40(2):412-414.
实体器官移植后诺卡菌病的结局与治疗:一项欧洲研究的新见解
Clin Infect Dis. 2017 May 15;64(10):1396-1405. doi: 10.1093/cid/cix124.
4
Increasing Nocardia Incidence Associated with Bronchiectasis at a Tertiary Care Center.在一家三级医疗中心,与支气管扩张相关的诺卡菌发病率上升。
Ann Am Thorac Soc. 2017 Mar;14(3):347-354. doi: 10.1513/AnnalsATS.201611-907OC.
5
Epidemiology and susceptibility to antimicrobial agents of the main Nocardia species in Spain.西班牙主要诺卡氏菌属菌种的流行病学及对抗菌药物的敏感性
J Antimicrob Chemother. 2017 Mar 1;72(3):754-761. doi: 10.1093/jac/dkw489.
6
Immunocompetence in adults: more than HIV negative.成人的免疫能力:不仅仅是HIV阴性。
Colomb Med (Cali). 2016 Sep 30;47(3):176.
7
Impact of immune status on the clinical characteristics and treatment outcomes of nocardiosis.免疫状态对诺卡菌病临床特征及治疗结果的影响。
Diagn Microbiol Infect Dis. 2016 Aug;85(4):482-7. doi: 10.1016/j.diagmicrobio.2016.05.004. Epub 2016 May 12.
8
Nocardiosis following hematopoietic stem cell transplantation.造血干细胞移植后诺卡菌病
Transpl Infect Dis. 2016 Apr;18(2):169-75. doi: 10.1111/tid.12499. Epub 2016 Mar 29.
9
Accurate Identification of Common Pathogenic Nocardia Species: Evaluation of a Multilocus Sequence Analysis Platform and Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry.常见致病性诺卡菌属菌种的准确鉴定:多基因座序列分析平台和基质辅助激光解吸电离飞行时间质谱的评估
PLoS One. 2016 Jan 25;11(1):e0147487. doi: 10.1371/journal.pone.0147487. eCollection 2016.
10
Antimicrobial susceptibility among clinical Nocardia species identified by multilocus sequence analysis.通过多位点序列分析鉴定的临床诺卡氏菌属菌种的抗菌药敏性。
Antimicrob Agents Chemother. 2015 Jan;59(1):269-75. doi: 10.1128/AAC.02770-14. Epub 2014 Oct 27.